Parnax Lab Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 286243,
    "name": "Parnax Lab",
    "stock_name": "Parnax Lab",
    "full_name": "Parnax Lab Ltd",
    "name_url": "stocks-analysis/parnax-lab",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "134.65",
    "chg": -0.95,
    "chgp": "-0.7%",
    "dir": -1,
    "prev_price": "135.60",
    "mcapval": "154.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 506128,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 49,
    "indexname": "India SENSEX",
    "isin": "INE383L01019",
    "curr_date": "Jun 18",
    "curr_time": "",
    "bse_nse_vol": "6.23 k",
    "exc_status": "Active",
    "traded_date": "Jun 18, 2026",
    "traded_date_str": "2026 06 18",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://marketsmojo.motilaloswal.com/MOSL-Landingstocks-analysis/parnax-lab-286243-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Parnax Lab Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-is-rated-hold-4000883",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ParnaxLabLtd_mojoScore_4000883.png",
        "date": "2026-05-20 10:10:03",
        "description": "Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Parnax Lab Ltd Valuation Shifts Signal Renewed Price Attractiveness",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parnax-lab-ltd-valuation-shifts-signal-renewed-price-attractiveness-4000015",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ParnaxLabLtd_valuationdot_4000015.png",
        "date": "2026-05-20 08:00:32",
        "description": "Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a previously fair to an attractive valuation grade. This change, coupled with a recent upgrade in its Mojo Grade from Strong Sell to Hold, signals a potential reappraisal of the stock’s price attractiveness amid improving fundamentals and relative sector comparisons."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Parnax Lab Ltd to 52-Week High of Rs 182",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parnax-lab-ltd-hits-new-52-week-high-at-rs182-mark-3985063",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ParnaxLabLtd_priceRelatedfactors_3985063.png",
        "date": "2026-05-11 09:40:32",
        "description": "Surging from a 52-week low of Rs 87.5 to a fresh peak of Rs 182, Parnax Lab Ltd has delivered an impressive 80.28% return over the past year, significantly outperforming the Sensex which declined by 3.93% during the same period. This milestone comes amid a backdrop of broad technical strength that has propelled the stock higher despite a weakening broader market."
      },
      {
        "title": "Parnax Lab Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-is-rated-hold-by-marketsmojo-3982933",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ParnaxLabLtd_mojoScore_3982933.png",
        "date": "2026-05-09 10:10:03",
        "description": "Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 Mar 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Parnax Lab Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-is-rated-hold-by-marketsmojo-3982944",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ParnaxLabLtd_mojoScore_3982944.png",
        "date": "2026-05-09 10:10:03",
        "description": "Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 Mar 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date view of the company's performance and outlook."
      },
      {
        "title": "Parnax Lab Ltd Valuation Shifts Signal Changing Market Perception",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parnax-lab-ltd-valuation-shifts-signal-changing-market-perception-3978629",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/ParnaxLabLtd_valuationdot_3978629.png",
        "date": "2026-05-07 08:00:38",
        "description": "Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change comes amid a strong rally in its stock price, which has outperformed the Sensex significantly over multiple time horizons. Investors and analysts are now reassessing the company’s price attractiveness in light of its current price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical averages and peer benchmarks."
      },
      {
        "title": "Parnax Lab Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/parnax-lab-ltd-is-rated-hold-by-marketsmojo-3966549",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ParnaxLabLtd_mojoScore_3966549.png",
        "date": "2026-04-28 10:10:03",
        "description": "Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with the most recent insights into the company’s performance and outlook."
      },
      {
        "title": "Broad-Based Technical Strength Lifts Parnax Lab Ltd to 52-Week High of Rs 169",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parnax-lab-ltd-hits-new-52-week-high-at-rs169-3966085",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ParnaxLabLtd_priceRelatedfactors_3966085.png",
        "date": "2026-04-28 09:40:31",
        "description": "With a 71.43% gain over the past year, Parnax Lab Ltd has surged from Rs 85.60 to a fresh 52-week high of Rs 169 on 28 Apr 2026, showcasing a remarkable price momentum that outpaces the Sensex’s decline of 3.70% over the same period."
      },
      {
        "title": "Parnax Lab Ltd Valuation Shifts to Fair Amid Strong Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/parnax-lab-ltd-valuation-shifts-to-fair-amid-strong-market-returns-3954793",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/ParnaxLabLtd_valuationdot_3954793.png",
        "date": "2026-04-21 08:00:17",
        "description": "Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. Despite this adjustment, the company’s stock has delivered robust returns over multiple time horizons, outperforming the Sensex significantly. This article analyses the recent valuation changes, compares key metrics with peers, and assesses the implications for investors."
      }
    ],
    "total": 15,
    "sid": "286243",
    "stock_news_url": "https://marketsmojo.motilaloswal.com/news/parnax-lab-286243"
  },
  "announcements": [
    {
      "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance",
      "datetime": "30-May-2026",
      "details": "Please find enclosed herewith the Annual Secretarial Compliance Report under reg. 24(A) for the Year ended March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Board Meeting Outcome For Consideration And Approval Of Standalone & Consolidated Audited Financial Results Of The Company For The Quarter And Year Ended 31St March 2026 Along With AuditorS Report Thereon.",
      "datetime": "28-May-2026",
      "details": "Board Meeting Outcome for Consideration and Approval of Standalone & Consolidated Audited Financial Results of the Company for the quarter and year ended 31st March 2026 along with Auditors Report thereon and Re-appointment of Mr. Yogesh Varia as an Independent Director.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "28-May-2026",
      "details": "Please find enclosed herewith the Intimation regarding the Re-appointment of Mr. Yogesh K. Varia as an Independent Director of the Company for a second term of 5 consecutive years w.e.f. 28th May 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Parnax Lab Ltd is Rated Hold

2026-05-20 10:10:03

Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 Mar 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 May 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Parnax Lab Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-05-20 08:00:32

Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from a previously fair to an attractive valuation grade. This change, coupled with a recent upgrade in its Mojo Grade from Strong Sell to Hold, signals a potential reappraisal of the stock’s price attractiveness amid improving fundamentals and relative sector comparisons.

Broad-Based Technical Strength Lifts Parnax Lab Ltd to 52-Week High of Rs 182

2026-05-11 09:40:32

Surging from a 52-week low of Rs 87.5 to a fresh peak of Rs 182, Parnax Lab Ltd has delivered an impressive 80.28% return over the past year, significantly outperforming the Sensex which declined by 3.93% during the same period. This milestone comes amid a backdrop of broad technical strength that has propelled the stock higher despite a weakening broader market.

Parnax Lab Ltd is Rated Hold by MarketsMOJO

2026-05-09 10:10:03

Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 Mar 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Parnax Lab Ltd is Rated Hold by MarketsMOJO

2026-05-09 10:10:03

Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 Mar 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 09 May 2026, providing investors with an up-to-date view of the company's performance and outlook.

Parnax Lab Ltd Valuation Shifts Signal Changing Market Perception

2026-05-07 08:00:38

Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. This change comes amid a strong rally in its stock price, which has outperformed the Sensex significantly over multiple time horizons. Investors and analysts are now reassessing the company’s price attractiveness in light of its current price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical averages and peer benchmarks.

Parnax Lab Ltd is Rated Hold by MarketsMOJO

2026-04-28 10:10:03

Parnax Lab Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 April 2026, providing investors with the most recent insights into the company’s performance and outlook.

Broad-Based Technical Strength Lifts Parnax Lab Ltd to 52-Week High of Rs 169

2026-04-28 09:40:31

With a 71.43% gain over the past year, Parnax Lab Ltd has surged from Rs 85.60 to a fresh 52-week high of Rs 169 on 28 Apr 2026, showcasing a remarkable price momentum that outpaces the Sensex’s decline of 3.70% over the same period.

Parnax Lab Ltd Valuation Shifts to Fair Amid Strong Market Returns

2026-04-21 08:00:17

Parnax Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair valuation grade. Despite this adjustment, the company’s stock has delivered robust returns over multiple time horizons, outperforming the Sensex significantly. This article analyses the recent valuation changes, compares key metrics with peers, and assesses the implications for investors.

View All News